Arvast 5mg 10 Tablets

Babies: Not applicable. Lactating mother: Arvast tablet is not safe to use during breastfeeding.
Some data have shown that this drug may cause toxicity to the baby. Pregnancy: Arvast tablet is not safe to use during pregnancy.
Human and animal studies have suggested that this drug may cause harmful effects on developing babies. Alcohol: Caution is advised while drinking alcohol with arvast tablets.
Consult your doctor. Driving: It is safe to drive after taking this medication.
Kidney: Arvast tablets must be used with caution in patients with kidney disease. Dose adjustment is required.
Consult your doctor. This medication is not prescribed in patients with severe kidney disease.
Liver: Arvast tablet must be used with caution in patients with liver disease. Dose adjustment is required.
Consult your doctor. This medication is not prescribed in patients with severe liver disease and active liver disease..

Muscle pain Weakness Headache Abdominal pain.

Arvast is antihyperlipidemic. It works by blocking the enzyme (hmg-coa reductase) required to produce cholesterol in the body.
Hence, it reduces bad cholesterol, triglycerides levels and increases good cholesterol..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Arvast tablet is used in the treatment of high cholesterol. Along with this medication, you must do regular exercise and take low-fat foods • It reduces the risk of future heart diseases like heart attack and stroke • It is better to take it after dinner before sleeping • This medication may cause diarrhoea, gas, or stomach upset.
So, it is better to take with food • Tell your doctor if you experienced muscle pain or discomfort • Inform your doctor if you are pregnant or breastfeeding • Your doctor may advise liver functions tests before and during the treatment • Consult your doctor if you notice or experienced with yellowing of your eyes, skin, or dark urine during this treatment • Before taking this medication, inform your doctor if you have liver, kidney, or diabetes • If you have diabetes, regular monitoring of blood sugar levels is required while taking this medication.

• Arvast + Atazanavir: Concurrent use may result in an increased risk of rosuvastatin toxicity, including the risk of myopathy or rhabdomyolysis • Arvast + Cyclosporine: Concurrent use may result in increased plasma concentrations and risk of myopathy • Arvast + Fenofibrate: Concurrent use may result in an increased risk of myopathy or rhabdomyolysis • Arvast + Indinavir: Concurrent use may result in increased plasma concentrations and risk of myopathy or rhabdomyolysis • Arvast + Niacin: Concurrent use may result in an increased risk of myopathy or rhabdomyolysis • Arvast + Aluminum phosphate: Concurrent use may result in decreased rosuvastatin effectiveness • Arvast + Magnesium carbonate: Concurrent use may result in decreased rosuvastatin effectiveness.